about
Vaccines: from empirical development to rational designVaccinology in the third millennium: scientific and social challengesLessons learned in the analysis of high-dimensional data in vaccinomicsAn Overview of Challenges Limiting the Design of Protective Mucosal Vaccines for FinfishA systems biology approach to the effect of aging, immunosenescence and vaccine responseInsights into the development of Ixodes scapularis: a resource for research on a medically important tick species.Cell-Based Systems Biology Analysis of Human AS03-Adjuvanted H5N1 Avian Influenza Vaccine Responses: A Phase I Randomized Controlled TrialThe personal touch: strategies toward personalized vaccines and predicting immune responses to them.Transcriptional signatures of influenza A/H1N1-specific IgG memory-like B cell response in older individualsGeVaDSs - decision support system for novel Genetic Vaccine development processAutoimmune and autoinflammatory mechanisms in uveitis.Transcriptional specialization of human dendritic cell subsets in response to microbial vaccines.An integrated metabonomic and proteomic study on Kidney-Yin Deficiency Syndrome patients with diabetes mellitus in ChinaSystems vaccinology: its promise and challenge for HIV vaccine development.Multigenic control of measles vaccine immunity mediated by polymorphisms in measles receptor, innate pathway, and cytokine genes.Consistency of HLA associations between two independent measles vaccine cohorts: a replication studyTherapeutic Vaccine Strategies against Human Papillomavirus.Integrated Strategy for Sustainable Cattle Fever Tick Eradication in USA is Required to Mitigate the Impact of Global Change.Transcriptional profiling of vaccine-induced immune responses in humans and non-human primates.Whole Transcriptome Profiling Identifies CD93 and Other Plasma Cell Survival Factor Genes Associated with Measles-Specific Antibody Response after Vaccination.Variability in Humoral Immunity to Measles Vaccine: New Developments.Understanding the immune response to seasonal influenza vaccination in older adults: a systems biology approachThe genetic basis for interindividual immune response variation to measles vaccine: new understanding and new vaccine approachesTranscriptomic profiles of high and low antibody responders to smallpox vaccine.Gene signatures related to HAI response following influenza A/H1N1 vaccine in older individuals.Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.Systems biological approaches to measure and understand vaccine immunity in humans.Molecular signatures of antibody responses derived from a systems biology study of five human vaccinesHarnessing RNA sequencing for global, unbiased evaluation of two new adjuvants for dendritic-cell immunotherapy.Future prospects and challenges of vaccines against filariasis.Basic research in HIV vaccinology is hampered by reductionist thinking.Systems approach to tuberculosis vaccine development.Efficient and Durable Vaccine against Intimin β of Diarrheagenic E. Coli Induced by Clay Nanoparticles.Coping with genetic diversity: the contribution of pathogen and human genomics to modern vaccinology.iTRAQ-based proteomic analysis to identify the molecular mechanism of Zhibai Dihuang Granule in the Yin-deficiency-heat syndrome rats.Vaccination choices for older people, looking beyond age specific approaches.
P2860
Q21089599-0940E47A-F5B1-4D0F-8E13-3847881565BCQ24261399-15A199EF-19B9-44CB-8687-A74A52DDFCBEQ24289396-096F98F6-6C01-4739-B7E0-495924DE582DQ26777943-C0E337A5-1B91-4A91-B2CE-B3B797D7C1CEQ26994749-B1E2CB4D-574A-4FA1-932B-66DACEF7AEF9Q27329896-76533486-3D67-4BEB-A54C-A71194E6671CQ30397652-E9D1778F-A22B-4FC0-93FC-163F5F745DCDQ33813977-F7940AAD-58A1-4D78-96FE-54AA08482FA0Q33922317-08CFD5BA-626E-4013-8704-F0A559CD0070Q34265324-9A5592BD-BFB0-4109-98FF-F263F5320C23Q34294964-36F363D2-59DE-48DF-8E3D-5C32A649F9B2Q34390332-1B222775-0943-4B52-AD0D-B502E33EAD9BQ35621303-1D0F288F-AE7D-4642-9BD8-1B9CE8A3CF45Q35659539-E3B3E2C8-CAE7-49B4-96FF-090D169315E7Q35784185-8C9C09AE-7B2D-4B92-A278-40C8016E4E0BQ35785581-0BCD84D3-8917-41B1-91BA-0CA38F810294Q35826752-E6E18FA5-7A22-4261-8C51-2B5218FCFCEAQ36031224-22CD6186-30CC-4270-9B07-DB324C8D7312Q36050652-E2AC7484-E717-4A93-8D79-5C7476D7C8C4Q36105040-BA9948A6-BCCB-46C5-9E42-552D8CFF01AEQ36373260-76C07108-1D43-4518-990C-C31810BB8EB2Q36445635-828C4FE0-B36B-488C-AFD0-645B8DDCCAF0Q36603325-88E6121E-DFDF-4F14-96A5-2E7FE62A366AQ37045834-38029AAC-63B6-41BD-B1E0-8D8F33060D71Q37097035-0A9F3DFF-01F8-4B50-B3C2-0CFFBAA6A199Q37119456-86237ADF-9B48-4432-B067-61CBDC32F306Q37232564-7CA830B4-1B6D-4978-8E55-FE6907EB43BAQ37625332-99A3A1D5-BC2B-4E90-9AB5-B26A59453C0AQ37746179-4C4BDDA5-743D-4D2E-9139-9EEB0416A04DQ37965765-A1BB7E41-59EE-47CC-BF2D-8C3941A9A31EQ38025633-6B63B4DA-0AE1-45B4-B5DA-1B350C90194DQ38075096-BB5399AB-6F9A-422A-B107-93ED740FE7C9Q39900815-83C0C96D-2CF9-4F3D-943D-FDB28E3D532AQ42040401-C1EA1C1C-4374-4514-82C6-92178B73EDDFQ47339402-437B8ECF-F17B-44B5-9640-52E38D1D6E9BQ47595817-D697FA55-8601-49D3-B2F5-59743DEC7255
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
name
Systems biology approaches to new vaccine development.
@ast
Systems biology approaches to new vaccine development.
@en
type
label
Systems biology approaches to new vaccine development.
@ast
Systems biology approaches to new vaccine development.
@en
prefLabel
Systems biology approaches to new vaccine development.
@ast
Systems biology approaches to new vaccine development.
@en
P2093
P2860
P1476
Systems biology approaches to new vaccine development.
@en
P2093
Ann L Oberg
Richard B Kennedy
P2860
P304
P356
10.1016/J.COI.2011.04.005
P577
2011-05-11T00:00:00Z